Tushar Shah
About
Tushar Shah is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy.
According to data from OpenAlex, Tushar Shah has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 19 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology and Allergy. Recurrent topics in Tushar Shah's work include Asthma and respiratory diseases (22 papers), Inhalation and Respiratory Drug Delivery (13 papers) and Respiratory and Cough-Related Research (12 papers). Tushar Shah is often cited by papers focused on Asthma and respiratory diseases (22 papers), Inhalation and Respiratory Drug Delivery (13 papers) and Respiratory and Cough-Related Research (12 papers). Tushar Shah collaborates with scholars based in United States, Spain and India. Tushar Shah's co-authors include Donald H. Horstman, Donald A. Mahler, Julie Yates, Chai‐Ni Chang, Tracy Fischer, Barbara A. Prillaman, Patrick Darken, Karen House, Leslie Baitinger and Benjamin Lee and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Journal of Allergy and Clinical Immunology.
In The Last Decade
Tushar Shah
22 papers receiving 1.4k citations
Peers
Tushar Shah
Kaarina Lehtonen Finland
C S Ulrik Denmark
S Holt United Kingdom
Nick Adams United Kingdom
Paula Pallasaho Finland
Simon Couillard Canada
Bilun Gemicioğlu Türkiye
Suzanne Marsh New Zealand
Marie‐Ève Boulay Canada
Inga Sif Ólafsdóttir Sweden
Citations per year, relative to Tushar Shah Tushar Shah (= 1×)
peers
Kaarina Lehtonen
Countries citing papers authored by Tushar Shah
Since
Specialization
Citations
This map shows the geographic impact of Tushar Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tushar Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tushar Shah more than expected).
Fields of papers citing papers by Tushar Shah
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Tushar Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tushar Shah. The network helps show where Tushar Shah may publish in the future.
Co-authorship network of co-authors of Tushar Shah
This figure shows the co-authorship network connecting the top 25 collaborators of Tushar Shah. A scholar is included among the top collaborators of Tushar Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tushar Shah. Tushar Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Shah, Tushar, et al.. (2020). Find A Loo: an app for sanitation governance. Information Communication & Society. 24(11). 1586–1602.
2.
Virchow, J. Christian, Roberto Rodríguez-Roisin, Alberto Papi, Tushar Shah, & Gokul Gopalan. (2016). A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma. BMC Pulmonary Medicine. 16(1). 42–42.
3.
LaForce, Craig, et al.. (2016). Efficacy and Safety of Albuterol Multidose Dry Powder Inhaler (MDPI) Versus Placebo in Children With Asthma. Journal of Allergy and Clinical Immunology. 137(2). AB209–AB209.
4.
Kerwin, Edward, et al.. (2015). Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir® Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies. Clinical Drug Investigation. 36(1). 55–65.
5.
Wolthers, Ole D. & Tushar Shah. (2014). A Comparison of Short-Term Growth During Treatment with Two Dry Powder Combinations of Inhaled Corticosteroids and Long-Acting β 2 -Agonists. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(3). 182–188.
6.
Gopalan, Gokul, et al.. (2013). Pharmacokinetics (PK) and safety of budesonide plus formoterol (BF) (160/4.5mcg) Spiromax® and BF (200/6mcg) Turbuhaler® following two inhalations (+/- charcoal [char] block) in healthy volunteers (HV). European Respiratory Journal. 42(Suppl 57). 4630–4630.
7.
Chervinsky, Paul, David L. Miller, Bruce M. Prenner, et al.. (2007). Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis. Annals of Allergy Asthma & Immunology. 99(1). 69–76.
8.
Ratner, Paul H., Patrick Darken, Mark A. Wingertzahn, & Tushar Shah. (2007). Ciclesonide and Beclomethasone Dipropionate Coadministration: Effect on Cortisol in Perennial Allergic Rhinitis. Journal of Asthma. 44(8). 629–633.
9.
Kim, Kenneth, et al.. (2007). Intranasal Ciclesonide Coadministration with Inhaled Fluticasone Propionate-Salmeterol does not Suppress Cortisol in Allergic Rhinitis Patients. Journal of Asthma. 44(7). 515–520.
10.
Ratner, Paul H., et al.. (2006). Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis. Annals of Allergy Asthma & Immunology. 97(5). 657–663.
11.
Nathan, Robert A., Paul Dorinsky, Jacqueline R. Carranza Rosenzweig, et al.. (2003). Improved Ability to Perform Strenuous Activities After Treatment with Fluticasone Propionate/Salmeterol Combination in Patients with Persistent Asthma. Journal of Asthma. 40(7). 815–822.
12.
Hanania, Nicola A., Patrick Darken, Donald H. Horstman, et al.. (2003). The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD. CHEST Journal. 124(3). 834–843.
13.
Mahler, Donald A., Donald H. Horstman, Chai‐Ni Chang, et al.. (2002). Effectiveness of Fluticasone Propionate and Salmeterol Combination Delivered via the Diskus Device in the Treatment of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 166(8). 1084–1091.
14.
Shapiro, Gail, William R. Lumry, James Wolfe, et al.. (2000). Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma. American Journal of Respiratory and Critical Care Medicine. 161(2). 527–534.
15.
Kavuru, Mani S., Julian Melamed, Gary N. Gross, et al.. (2000). Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial. Journal of Allergy and Clinical Immunology. 105(6). 1108–1116.
16.
Nelson, Harold S., William W. Busse, Bennett P. deBoisblanc, et al.. (1999). Fluticasone propionate powder: Oral corticosteroid–sparing effect and improved lung function and quality of life in patients with severe chronic asthma. Journal of Allergy and Clinical Immunology. 103(2). 267–275.
17.
Szefler, Stanley J., Homer A. Boushey, David S. Pearlman, et al.. (1999). Time to onset of effect of fluticasone propionate in patients with asthma. Journal of Allergy and Clinical Immunology. 103(5). 780–788.
18.
Li, James T.C., Linda B. Ford, Paul Chervinsky, et al.. (1999). Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. Journal of Allergy and Clinical Immunology. 103(6). 1062–1068.
19.
Pearlman, David S., W. Stricker, Steven F. Weinstein, et al.. (1999). Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Annals of Allergy Asthma & Immunology. 82(3). 257–265.
20.
Nielsen, Kirsten Vang, L Okamoto, & Tushar Shah. (1997). Importance of Selected Inhaler Characteristics and Acceptance of a New Breath-Actuated Powder Inhalation Device. Journal of Asthma. 34(3). 249–253.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kaarina Lehtonen Breakdown of academic impact, for papers by C S Ulrik Breakdown of academic impact, for papers by S Holt Breakdown of academic impact, for papers by Nick Adams Breakdown of academic impact, for papers by Paula Pallasaho Breakdown of academic impact, for papers by Simon Couillard Breakdown of academic impact, for papers by Bilun Gemicioğlu Breakdown of academic impact, for papers by Suzanne Marsh Breakdown of academic impact, for papers by Marie‐Ève Boulay Breakdown of academic impact, for papers by Inga Sif Ólafsdóttir